Isomorphic Labs

What Isomorphic Labs does

Isomorphic Labs is dedicated to advancing human health by building on and beyond the Nobel-winning AlphaFold system. They have developed a unified, state-of-the-art drug design engine that leverages powerful new predictive and generative AI models to accelerate scientific discovery at digital speed. Their mission is to solve all disease by transforming how new drugs are designed and ultimately changing how medicine helps and heals people.

Products

• Drug Design EngineA unified, state-of-the-art engine that uses predictive and generative AI models to transform how new drugs are designed, enabling the tackling of multiple therapeutic areas and drug modalities.

Key capabilities

• Building on and beyond the Nobel-winning AlphaFold system
• Unified, state-of-the-art drug design engine
• Powerful new predictive AI models
• Powerful new generative AI models
• Accelerates scientific discovery at digital speed
• Enables tackling multiple therapeutic areas
• Enables tackling multiple drug modalities

Use cases

• Designing novel molecules
• Anticipating how drugs will perform
• Developing innovative medicines to treat and cure devastating diseases
• Translating research into transformational treatments for patients globally

AI approach

Isomorphic Labs uses machine learning to transform drug discovery, building on and beyond the Nobel-winning AlphaFold system. They have developed a unified, state-of-the-art drug design engine that uses powerful new predictive and generative AI models to accelerate scientific discovery and design novel molecules, anticipate drug performance, and develop innovative medicines.

Tech named: machine learning, predictive AI models, generative AI models, AlphaFold

Industries served

• Biotechnology Research
• Drug Discovery and Design

What it says sets it apart

• Building on and beyond the Nobel-winning AlphaFold system
• Interdisciplinary team of drug discovery experts and machine learning specialists
• Unified, state-of-the-art drug design engine
• Focus on digital biology and AI to solve all disease
• Leadership includes Nobel laureate Jennifer Doudna on Scientific Advisory Board

Funding rounds we track

From the AI funding tracker — rounds as reported by the linked publications.